Journal articles on the topic 'HCV'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'HCV.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
CRAMP, M. E. "HBV + HCV = HCC?" Gut 45, no. 2 (1999): 168–69. http://dx.doi.org/10.1136/gut.45.2.168.
Full textPaula, Cácia Régia de, Karynne Borges Cabral, Hildete Oliveira Ferreira Dos Prazeres, et al. "Tendência temporal das hepatites virais: A, B, C e B+ C, no estado de Goiás: estudo ecológico." CONTRIBUCIONES A LAS CIENCIAS SOCIALES 18, no. 2 (2025): e15300. https://doi.org/10.55905/revconv.18n.2-111.
Full textMujeeb, Syed Abdul, Qamar Jamal, Rafique Khanani, Nayyer Iqbal, and Shahnaz Kaher. "Prevalence of Hepatitis B Surface Antigen and HCV Antibodies in Hepatocellular Carcinoma Cases in Karachi, Pakistan." Tropical Doctor 27, no. 1 (1997): 45–46. http://dx.doi.org/10.1177/004947559702700117.
Full textStroffolini, Tommaso, and Giacomo Stroffolini. "A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma." Cancers 15, no. 8 (2023): 2388. http://dx.doi.org/10.3390/cancers15082388.
Full textHuang, Yen-Tsung, Chin-Lan Jen, Hwai-I. Yang, et al. "Lifetime Risk and Sex Difference of Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B and C." Journal of Clinical Oncology 29, no. 27 (2011): 3643–50. http://dx.doi.org/10.1200/jco.2011.36.2335.
Full textPár, Alajos. "Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma." Orvosi Hetilap 150, no. 1 (2009): 19–26. http://dx.doi.org/10.1556/oh.2009.28529.
Full textHaberl, Elisabeth M., Thomas S. Weiss, Georg Peschel, et al. "Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma." International Journal of Molecular Sciences 22, no. 10 (2021): 5297. http://dx.doi.org/10.3390/ijms22105297.
Full textFang, Lily, Amanda Yu, and Jane A. Buxton. "Identification of Acute Vaccine-Preventable Hepatitis in Individuals with Chronic Hepatitis in British Columbia between 1991 and 2007." Canadian Journal of Infectious Diseases and Medical Microbiology 22, no. 1 (2011): 10–14. http://dx.doi.org/10.1155/2011/564290.
Full textBuxton, Jane A., and Jin Hee Kim. "Hepatitis A and Hepatitis B Vaccination Responses in Persons with Chronic Hepatitis C Infections: A Review of the Evidence and Current Recommendations." Canadian Journal of Infectious Diseases and Medical Microbiology 19, no. 2 (2008): 197–202. http://dx.doi.org/10.1155/2008/410362.
Full textShen, Yu-Chuan, Hui-Ching Hsu, Tzu-Min Lin, et al. "H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection." Journal of Clinical Oncology 40, no. 11 (2022): 1206–19. http://dx.doi.org/10.1200/jco.21.01802.
Full textAlhamadany, Alaa Younis Mahdy, and Wajdi Sabeeh Sadek. "Analysis of the Chromosomal Aberrations in Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Hepatocellular Carcinoma Patients (HCC) in Mosul City, Iraq." NTU Journal of Pure Sciences 1, no. 2 (2022): 48–53. http://dx.doi.org/10.56286/ntujps.v1i2.210.
Full textKuo, Yuan-Hung, Tzu-Hsin Huang, Jing-Houng Wang, et al. "Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib." Cancers 14, no. 16 (2022): 3971. http://dx.doi.org/10.3390/cancers14163971.
Full textAlhamadany, Alaa Younis Mahdy, and Wajdi Sabeeh Sadek. "Evaluation of the genotoxicity in patients with HBV, HCV, and HCC using micronucleus and comet assay in Mosul City\Iraq." International journal of health sciences 6, S1 (2022): 1567–79. http://dx.doi.org/10.53730/ijhs.v6ns1.4903.
Full textMbaga, Donatien Serge, Sebastien Kenmoe, Cyprien Kengne-Ndé, et al. "Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders." PLOS ONE 17, no. 1 (2022): e0262903. http://dx.doi.org/10.1371/journal.pone.0262903.
Full textSethi, Amna Ameen, and Nisar Ahmed Shar. "Molecular insights into the viral etiologies in liver cancer." Pakistan Journal of Science 76, no. 04 (2024): 522–29. https://doi.org/10.57041/vol76iss04pp522-529.
Full textAlhamadany, Alaa Younis Mahdy, and Wajdi Sabeeh Sadek. "Evaluation of the genotoxicity and genomic instability in patients with HBV, HCV and HCC using micronucleus and comet assay." NTU Journal of Pure Sciences 1, no. 2 (2022): 54–63. http://dx.doi.org/10.56286/ntujps.v1i2.214.
Full textJiang, Joy, Meredith S. Shiels, Donna Rivera, Marc G. Ghany, Eric A. Engels, and Thomas R. O’Brien. "Trends in hepatocellular carcinoma and viral hepatitis treatment in older Americans." PLOS ONE 19, no. 11 (2024): e0307746. http://dx.doi.org/10.1371/journal.pone.0307746.
Full textDickson-Spillmann, Maria, Severin Haug, Ambros Uchtenhagen, Philip Bruggmann, and Michael P. Schaub. "Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection." European Addiction Research 22, no. 4 (2015): 181–91. http://dx.doi.org/10.1159/000441973.
Full textvon Drygalski, Annette, Niamh O'Connell, Peter Verhamme, et al. "Adult Patients with Hemophilia B and with a History of Chronic HCV/HBV Infection Receiving Liver-Directed Gene Therapy Demonstrated Long-Term Bleeding Protection and Sustained FIX Activity: Efficacy and Safety Results from the HOPE-B Trial 3 Years after Administration of a Single Dose of Etranacogene Dezaparvovec." Blood 142, Supplement 1 (2023): 2258. http://dx.doi.org/10.1182/blood-2023-188921.
Full textNavas, Maria-Cristina, Iris Suarez, Andrea Carreño, et al. "Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia." Hepatitis Research and Treatment 2011 (October 31, 2011): 1–10. http://dx.doi.org/10.1155/2011/582945.
Full textYaro, Abubakar, Svetoslav Martinov, and Catherine Johnson. "Efficacy of combined antiretroviral therapy (cART) in Hepatitis B and C associated hepatocellular carcinoma (HCC): a narrative review." Journal of Human Virology & Retrovirology 10, no. 3 (2023): 73–78. http://dx.doi.org/10.15406/jhvrv.2023.10.00271.
Full textMinuk, GY, M. Zhang, SGM Wong, et al. "Viral Hepatitis in a Canadian First Nations Community." Canadian Journal of Gastroenterology 17, no. 10 (2003): 593–96. http://dx.doi.org/10.1155/2003/978162.
Full textLu, Meng-Chuan, Ying-Hsuen Wu, Chi-Hsiang Chung, et al. "Association of Hepatitis B and C Virus with the Risk of Coronary Artery Disease and Cerebrovascular Disease in Patients with Hepatocellular Carcinoma." Journal of Clinical Medicine 12, no. 7 (2023): 2602. http://dx.doi.org/10.3390/jcm12072602.
Full textDuan, Jingxian, Tianhao Mu, and Shifu Chen. "The mutation profiles of HBV or HCV infected hepatocellular carcinoma patients underlie the varied responses to second-line immunotherapy." Journal of Clinical Oncology 38, no. 15_suppl (2020): e16629-e16629. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e16629.
Full textLiu, Weibo. "The transmission route of hepatitis A, B, and C virus and its pathological changes on the liver." Theoretical and Natural Science 48, no. 1 (2024): 15–21. http://dx.doi.org/10.54254/2753-8818/48/2024pj0111.
Full textSchotten, Clemens, Bastian Ostertag, Jan-Peter Sowa, et al. "GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients." Pharmaceuticals 14, no. 8 (2021): 735. http://dx.doi.org/10.3390/ph14080735.
Full textAwadh, Abdullah A., Abdulrahman A. Alharthi, Basil A. Alghamdi, et al. "Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma: Systematic Review and Meta-analysis." Journal of Global Infectious Diseases 16, no. 4 (2024): 127–34. https://doi.org/10.4103/jgid.jgid_211_23.
Full textRahman, Md Tahminur, Rosy Sultana, and Sohel Reza Chowdhury. "Seropositivity and pattern of viral hepatitis in clinically suspected cases of hepatitis in Dhaka city." Bangladesh Medical Research Council Bulletin 33, no. 3 (2010): 103–6. http://dx.doi.org/10.3329/bmrcb.v33i3.1142.
Full textAlqahtani, Saleh A., and Massimo Colombo. "Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma." Cells 10, no. 11 (2021): 3091. http://dx.doi.org/10.3390/cells10113091.
Full textShao, Yu Yun, Min-Shu Hsieh, Chung-Yi Huang, Yung-Ling Chang, Chih-Hung Hsu, and Ann-Lii Cheng. "Vascular endothelial growth factor expression in hepatitis C virus (HCV)-related advanced hepatocellular carcinoma (HCC) compared with hepatitis B virus (HBV)-related advanced HCC." Journal of Clinical Oncology 31, no. 15_suppl (2013): 4115. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4115.
Full textGaly, Olivier, Isabelle Chemin, Emilie Le Roux, et al. "Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand." Hepatitis Research and Treatment 2011 (June 30, 2011): 1–9. http://dx.doi.org/10.1155/2011/697162.
Full textAimla, Kerstin, Justyna Dominika Kowalska, Raimonda Matulionyte, et al. "Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group." Vaccines 11, no. 5 (2023): 980. http://dx.doi.org/10.3390/vaccines11050980.
Full textHester, Caitlin A., Nicole E. Rich, Amit G. Singal, and Adam C. Yopp. "Comparative Analysis of Nonalcoholic Steatohepatitis– Versus Viral Hepatitis– and Alcohol-Related Liver Disease–Related Hepatocellular Carcinoma." Journal of the National Comprehensive Cancer Network 17, no. 4 (2019): 322–29. http://dx.doi.org/10.6004/jnccn.2018.7105.
Full textKaliaskarova, Kulpash. "Aspects of Cancer Prevention of the Main Precursors of Liver Carcinoma - Viral hepatitis." Oncology.kz, no. 8 (August 15, 2023): 13–17. https://doi.org/10.56598/2957-6377-2023-8-13-17.
Full textAkashi, Hayato, and Masaaki Hidaka. "Comparison of the pathological features among HBV, HCV, and nonviral etiology-related hepatocellular carcinoma using explanted whole liver examinations." Journal of Clinical Oncology 35, no. 4_suppl (2017): 245. http://dx.doi.org/10.1200/jco.2017.35.4_suppl.245.
Full textPatt, Y. Z., C. Charnsangavej, B. Yoffe, et al. "Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival." Journal of Clinical Oncology 12, no. 6 (1994): 1204–11. http://dx.doi.org/10.1200/jco.1994.12.6.1204.
Full textCortes-Mancera, Fabian, Carmen Luisa Loureiro, Sergio Hoyos, et al. "Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia." Hepatitis Research and Treatment 2011 (September 20, 2011): 1–10. http://dx.doi.org/10.1155/2011/363205.
Full textCranford, Hannah M., Patricia Denise Jones, Qinran Liu, Tulay Koru-Sengul, Isildinha M. Reis, and Paulo S. Pinheiro. "Hepatocellular carcinoma etiology drives survival outcomes: A population-based analysis." Journal of Clinical Oncology 42, no. 16_suppl (2024): e16142-e16142. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e16142.
Full textPetruzziello, Arnolfo. "Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma." Open Virology Journal 12, no. 1 (2018): 26–32. http://dx.doi.org/10.2174/1874357901812010026.
Full textYen, Yi-Hao, Kwong-Ming Kee, Wei-Feng Li, et al. "Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology." Cancers 15, no. 6 (2023): 1687. http://dx.doi.org/10.3390/cancers15061687.
Full textTong, C. Y. W., R. Khan, N. J. Beeching, et al. "The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellula carcinoma." Epidemiology and Infection 117, no. 2 (1996): 327–32. http://dx.doi.org/10.1017/s0950268800001503.
Full textPseush, S. Yu, L. V. Zozulya, and L. L. Mikhaleva. "The predictive value indicators of first trimester biochemical screening in assessing unfavorable factors of pregnancy course in women with HIV as well as hepatitis B and C." Obstetrics, Gynecology and Reproduction 15, no. 6 (2022): 686–94. http://dx.doi.org/10.17749/2313-7347/ob.gyn.rep.2021.240.
Full textQiu, Jinrong, Weifeng Wang, Yingmei Li, and Shifu Chen. "Comparison of mutational landscape of non-alcoholic fatty liver disease, viral hepatitis, and alcohol consumption related hepatocellular carcinoma." Journal of Clinical Oncology 38, no. 15_suppl (2020): e16614-e16614. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e16614.
Full textJain, Rajeev K., Rakesh Shrivastava, Shailendra K. Jain, et al. "Seropositivity and coinfection of hepatitis B and hepatitis C viruses in Central India: A hospital-based study." Journal of Family Medicine and Primary Care 13, no. 10 (2024): 4413–18. http://dx.doi.org/10.4103/jfmpc.jfmpc_202_24.
Full textHuang, Xiao-wen, Bing Liao, Yang Huang, et al. "Non-Invasive Diagnostic Criteria for Hepatocellular Carcinoma in Hepatitis B Virus-Endemic Areas: Is Cirrhosis Indispensable?" Digestive Diseases 36, no. 3 (2018): 228–35. http://dx.doi.org/10.1159/000486196.
Full textKishta, Sara, Ashraf Tabll, Tea Omanovic Kolaric, Robert Smolic, and Martina Smolic. "Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals." Biomedicines 8, no. 6 (2020): 175. http://dx.doi.org/10.3390/biomedicines8060175.
Full textKanda, Tatsuo, Taichiro Goto, Yosuke Hirotsu, Mitsuhiko Moriyama, and Masao Omata. "Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review." International Journal of Molecular Sciences 20, no. 6 (2019): 1358. http://dx.doi.org/10.3390/ijms20061358.
Full textAndressa de Farias Fehlberg, Joelma Lessa da Silva, Roberta Pinho Gomes, and Rachel Siqueira de Queiroz Simões. "Immunological serum markers for hepatitis viral infections: HAV, HBV, HCV to advance of genetic engineering." GSC Biological and Pharmaceutical Sciences 25, no. 1 (2023): 118–30. http://dx.doi.org/10.30574/gscbps.2023.25.1.0394.
Full textAndressa, de Farias Fehlberg, Lessa da Silva Joelma, Pinho Gomes Roberta, and Siqueira de Queiroz Simões Rachel. "Immunological serum markers for hepatitis viral infections: HAV, HBV, HCV to advance of genetic engineering." GSC Biological and Pharmaceutical Sciences 25, no. 1 (2023): 118–30. https://doi.org/10.5281/zenodo.10578863.
Full textAlhaqbani, Abdulaziz H., Abdulaziz Almusalam, Abdulaziz Alnadhari, et al. "The prevalence and associated factors of viral hepatitis and cryptogenic related hepatocellular carcinoma at King Abdulaziz Medical city-Riyadh." International Journal Of Community Medicine And Public Health 6, no. 2 (2019): 561. http://dx.doi.org/10.18203/2394-6040.ijcmph20190060.
Full text